Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1130/week)
    • Manufacturing(535/week)
    • Technology(1037/week)
    • Energy(452/week)
    • Other Manufacturing(337/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Alkermes

Jun 22, 2020
New Preclinical Data on ALKS 4230 in Combination With Lucitanib to be Presented at 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
Jun 04, 2020
Alkermes to Take Part in 41st Annual Goldman Sachs Global Healthcare Conference
May 14, 2020
Alkermes Presents New Data From Schizophrenia Portfolio at Virtual 2020 Congress of the Schizophrenia International Research Society
May 11, 2020
Alkermes Announces Expansion of Patient Services and Provider Network to Support Uninterrupted Access to ARISTADA® and VIVITROL® During COVID-19 Crisis
May 06, 2020
Alkermes Announces Upcoming Presentation at the Bank of America Securities Virtual Health Care Conference
May 04, 2020
Alkermes Launches COVID-19 Relief Fund to Support Innovative Programs Helping Vulnerable Patient Communities
Apr 29, 2020
Alkermes Plc Reports First Quarter 2020 Financial Results and Provides COVID-19 Related Business Update
Apr 22, 2020
Alkermes to Host Conference Call to Discuss First Quarter 2020 Financial Results
Apr 22, 2020
Alkermes Announces Publication of Preclinical Data for ALKS 4230 in the Journal for ImmunoTherapy of Cancer
Mar 04, 2020
Journal of Clinical Psychiatry Publishes Data from Alkermes' Phase 3 ENLIGHTEN-1 Efficacy Study of ALKS 3831 in Patients With Schizophrenia
Feb 24, 2020
Alkermes' Corporate Presentation to be Webcast at the Cowen and Company 40th Annual Health Care Conference
Feb 06, 2020
Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results
Jan 28, 2020
Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder
Jan 08, 2020
Alkermes' Corporate Presentation to be Webcast at the 38th Annual J.P. Morgan Healthcare Conference
Nov 26, 2019
Alkermes to Present at the Evercore ISI 2nd Annual HealthCONx Conference
Nov 25, 2019
Alkermes Completes Acquisition of Rodin Therapeutics
Nov 19, 2019
Alkermes Submits New Drug Application to U.S. Food and Drug Administration for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder
Nov 18, 2019
Alkermes to Acquire Rodin Therapeutics
Nov 12, 2019
Alkermes' Corporate Presentation to be Webcast at Upcoming Healthcare Conferences
Nov 12, 2019
Alkermes Announces Receipt of $150 Million Milestone Payment from Biogen Related to FDA Approval of VUMERITY(TM)
  •  
  • Page 1
  • ››

Latest News

Jul 22, 2025

NRG Energy, Inc. to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 22, 2025

JF Expands Operations in Texas, Florida, and Illinois

Jul 22, 2025

NRG Energy, Inc. Announces Quarterly Dividend

Jul 22, 2025

Oil States Announces Second Quarter 2025 Earnings Conference Call

Jul 22, 2025

Karman Space & Defense Releases Preliminary Second Quarter Fiscal Year 2025 Financial Results in...

Jul 22, 2025

Karman Space & Defense Announces Proposed Public Offering of Common Stock

Jul 22, 2025

5Star Life Insurance Company Appoints John D. Naum Chief Financial Officer

Jul 22, 2025

Sitio Royalties Announces Revised Date for Second Quarter 2025 Earnings Release

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia